Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis

ClinicalTrials.gov ID: NCT04475432

Public ClinicalTrials.gov record NCT04475432. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Controlled, Multicenter, Double-Masked, Parallel, Phase 2b/3 Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis

Study identification

NCT ID
NCT04475432
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Tarsus Pharmaceuticals, Inc.
Industry
Enrollment
421 participants

Conditions and interventions

Conditions

Interventions

  • TP-03, 0.25% Drug
  • TP-03 Vehicle Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 8, 2020
Primary completion
May 3, 2021
Completion
May 3, 2021
Last update posted
Dec 20, 2023

2020 – 2021

United States locations

U.S. sites
15
U.S. states
12
U.S. cities
14
Facility City State ZIP Site status
Cornea and Cataract Consultants of Arizona Phoenix Arizona 85032
Eye Research Foundation Newport Beach California 92663
Visionary Eye Institute Newport Beach California 92663
Vision Institute Colorado Springs Colorado 80907
Midwest Cornea Associates, LLC Carmel Indiana 46290
Washburn Research LLC Indianapolis Indiana 46240
The Eye Care Institute Louisville Kentucky 40206
Andover Eye Associates Andover Massachusetts 01810
Ophthalmology Associates St Louis Missouri 63131
Oculus Research, Inc at EyecareCenter Raleigh North Carolina 27603
Vita Eye Clinic Shelby North Carolina 28150
Scott & Christie and Associates, PC Cranberry Township Pennsylvania 16066
Total Eye Care, P.A. Memphis Tennessee 38119
Alpine Research Organization Layton Utah 84041
Piedmont Eye Center Lynchburg Virginia 24502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04475432, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 20, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04475432 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →